1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Spinal Dysraphism: new trials by email Literature Review of Spinal Dysraphism trials Research Report on Spinal Dysraphism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives Norgestimate-ethinyl estradiol, with or without folic acid - Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Phase 3 | Withdrawn | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2016-09-20 |
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Nervous System Diseases (1) · Nervous System Malformations (1) · Neural Tube Defects (1)
Moxifloxacin (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)